论文部分内容阅读
高血压是心血管系统疾病的主要危险因素,降压治疗有助于降低患者心血管危险水平并改善其预后。在我国,目前的高血压防治形势仍不容乐观。由高血压所导致的致死、致残性心血管疾病给整个社会带来沉重的经济负担,因此应充分重视并加强高血压防治。根据现有循证医学证据,高血压患者的血压水平应控制在140/90mmHg(1mmHg=0.133kPa)以下,部分高危患者的目标血压应更低。改善生活方式应被视为降压治疗的基石。联合用药是提高达标率的有效措施,固定复方制剂应成为中重度高血压防治的一线用药。各级行政管理部门应积极介入高血压的防控工作中,以期更为有效地提高降压治疗达标率。
Hypertension is a major risk factor for cardiovascular disease. Antihypertensive therapy can help reduce cardiovascular risk and improve prognosis in patients. In our country, the current situation of prevention and treatment of hypertension is still not optimistic. The lethal and disabling cardiovascular diseases caused by high blood pressure bring a heavy financial burden to the whole society. Therefore, full attention should be paid to the prevention and treatment of hypertension. According to available evidence-based evidence, blood pressure levels in patients with hypertension should be controlled at 140 / 90mmHg (1mmHg = 0.133kPa) below the target high blood pressure in some patients should be lower. Improving lifestyle should be considered the cornerstone of antihypertensive treatment. Combination of drugs is to improve the compliance rate of effective measures, fixed compound preparations should become the first-line treatment of moderate-to-severe hypertension. Administrative departments at all levels should actively intervene in the prevention and control of hypertension in order to more effectively improve the compliance rate of antihypertensive treatment.